Search Results 411-420 of 18880 for Neutrophil

1. Viral Therapy in Treating Patient with Liver Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1000/mm^3; Platelet count ≥ 80,000/mm^3; Hemoglobin ≥ 10 g/dl; Aspartate aminotransferase (AST)/alanine aminotransferase ...

2. A Study of the Safety and Drug/Body Interactions of BGB-3111 for Patients with B-Cell Lymphoid Malignancies - Mayo Clinic

   ... neutrophils < 1.0 x 10^9/L due to marrow infiltration are allowed to receive growth factors to bring pre-treatment neutrophils to ≥ 1.0 x 10^9/L. Adequate ...

3. Study to Evaluate Chemoembolization Combined with Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma - Mayo Clinic

   Absolute neutrophil count ≥1000/µL;; Platelet count ≥ 75000/µL;; Total bilirubin ≤ 2.0 × the upper limit of normal (ULN);; Alanine aminotransferase (ALT) ...

4. Autologous DC Vaccine For RRP Patients - Mayo Clinic

   The following laboratory values obtained ≤ 28 days prior to registration. Absolute neutrophil count (ANC) ≥ 1.0 x 109 /L; Platelet count (PLT) ≥ 75 x 109 ...

5. A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy - Mayo Clinic

   Absolute neutrophil count (ANC) <1,000/μL (1.0 X 109/L); Platelet count <50,000/μL (50 X 109/L); Serum aspartate aminotransferase (AST)/serum glutamic ...

6. Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell Transplant - Mayo Clinic

   Absolute neutrophil count ≥ 1,000/uL; Platelet count ≥ 75,000/uL; Hemoglobin ≥ 8.0 g/dL; Previous diagnosis of symptomatic multiple myeloma (MM); Received ...

7. A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

   Neutrophils ≥ 0.75 ... Ongoing toxicity of ≥ Grade 2 from prior anticancer therapy (except for alopecia, absolute neutrophil count [ANC] and platelets).

8. Alternate Doses and Dosing Schedules of Belantamab Mafodotin for the Treatment of Triple-Class Recurrent and/or Refractory Multiple Myeloma - Mayo Clinic

   - Absolute neutrophil count >= 1.0 x 10^9/L (=< 28 days prior to registration) - Without growth factor support, blood transfusion, or platelet stimulating ...

9. Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II) - Mayo Clinic

   - Absolute neutrophil count (ANC) >= 1,000/mm^3 - Platelet count >= 100,000/mm^3 - Creatinine =< 1.5 x upper limit of normal (ULN) - Aspartate ...

10. Clinical trials - Oncology (Medical)

    MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) ...